#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Germ cell cancer Extraskeletal ossification Hypomagnesaemia Ovarian cancer stage IV Kaposi's sarcoma Mantle cell lymphoma stage III Small cell lung cancer extensive stage Burkitt's lymphoma Ewing's sarcoma metastatic Glomerulonephritis acute Prophylaxis against transplant rejection Cystic fibrosis respiratory infection suppression Neuroblastoma Osteochondrodysplasia Richter's syndrome More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Trials in Disease Richter’s syndrome – Life with Disease Pulmonary fibrosis – Diagnostics Optic glioma – Life with Disease Skin angiosarcoma Pemphigoid – Diagnostics Langerhans cell sarcoma – Life with Disease Mantle cell lymphoma stage III – Treatment Urea cycle disorder – Diagnostics Mantle cell lymphoma stage IV – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoprolol Succinate BNT327 XMAB942 Divarasib Leriglitazone LTI-03 Disitamab Vedotin Sertraline Hydrochloride Adalimumab Zidovudine Lutropin Alfa Eliglustat Tartrate 177Lu-Rhpsma-10.1 Gallium (68Ga) Gozetotide Fluocinolone Acetonide Migalastat Atomoxetine Sunitinib Tecovirimat Gns561 More therapies…

    Learn about Your Condition

    Craniosynostosis Vomiting Right ventricular dysfunction Still's disease Hodgkin's disease Erectile dysfunction Hypoxia Peripheral artery angioplasty Follicular lymphoma stage II Hyperparathyroidism secondary Malignant peritoneal neoplasm Pulmonary embolism Tubulointerstitial nephritis Desmoplastic melanoma Constipation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    Italy

  • Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

    Recruiting

    3 1 1
    Investigated Drugs:
    • Deucrictibant
    Austria Bulgaria France Germany Hungary Ireland +5

  • Long-term safety and effectiveness study of atacicept in patients with IgA nephropathy (IgAN)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Atacicept
    Belgium Czechia Germany Greece Poland Spain

  • Study on Protamine Sulfate for Reducing Bleeding and Ischemic Events in Adults with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

    Recruiting

    3 1 1
    Investigated Drugs:
    • Protamine Sulfate
    Austria Germany

  • Study on Adjusted Ciprofloxacin Dosing for Patients with Kidney Impairment and Bacterial Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    The Netherlands

  • Study on the Safety of Tumor Treating Fields with Oxaliplatin, Calcium Folinate, Irinotecan Hydrochloride, and Fluorouracil for Metastatic Pancreatic Cancer Patients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Irinotecan Hydrochloride
    Spain
Previous Page
1 … 266 267 268 269 270 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!